Fig. 1.

Within-group and between-group analyses
| Variables | Study group | Control group | p-value (between groups) | F-value (between groups) | Ƞ2 |
|---|---|---|---|---|---|
| Weight (kg) | |||||
| Pre-treatment | 77.39 ± 5.43 | 77.56 ± 4.3 | 0.9a | 0.01 | |
| Post-treatment | 69.3 ± 5.41 | 73.18 ± 4.01 | 0.0009b | 7.59 | 0.15 |
| p-value (within-group) | 0.0001b | 0.0001b | |||
| MD (95% CI) | 8.08 (7.48 to 8.69) | 4.39 (3.78 to 4.99) | |||
| % of improvement | 10.4 % | 5.6 % | |||
| BMI (kg/m2) | |||||
| Pre-treatment | 28.62 ± 1.14 | 28.37 ± 1.13 | 0.46b | 0.54 | |
| Post-treatment | 25.62 ± 1.34 | 26.77 ± 1.18 | 0.004b | 9.36 | 0.18 |
| p-value (within-group) | 0.0001b | 0.0001b | |||
| MD (95% CI) | 2.99 (2.78 to 3.2) | 1.6 (1.39 to 1.8) | |||
| % of improvement | 10.5 % | 5.6 % | |||
| WHR | |||||
| Pre-treatment | 0.8 ± 0.04 | 0.81 ± 0.05 | 0.49a | 0.48 | |
| Post-treatment | 0.75 ± 0.05 | 0.79 ± 0.04 | 0.009b | 7.48 | 0.5 |
| p-value (within-group) | 0.0001b | 0.09a | |||
| MD (95% CI) | 0.05 (0.03 to 0.07) | 0.018 (0.003 to 0.03) | |||
| % of improvement | 6.2 % | 2.2 % | |||
| HOMA-IR | |||||
| Pre-treatment | 4.13 ± 0.87 | 3.97 ± 1.02 | 0.58a | 0.31 | |
| Post-treatment | 2.58 ± 0.42 | 3.19 ± 0.8 | 0.03b | 4.7 | 0.09 |
| p-value (within-group) | 0.0001b | 0.0001b | |||
| MD (95% CI) | 1.54 (1.4 to 1.69) | 0.77 (0.63 to 0.92) | |||
| % of improvement | 37.2 % | 19.4 % | |||
| LH/FSH ratio | |||||
| Pre-treatment | 1.95 ± 0.32 | 2.32 ± 0.53 | 0.18a | 1.87 | |
| Post-treatment | 1.41 ± 0.44 | 1.81 ± 0.68 | 0.02b | 5.63 | 0.11 |
| p-value (within-group) | 0.0001b | 0.001b | |||
| MD (95% CI) | 0.53 (0.28 to 0.79) | 0.5 (0.24 to 0.76) | |||
| % of improvement | 27.2 % | 21.5 % | |||
Schedule of enrollment, intervention, and assessment (SPIRIT)
| Participant characteristics | Enrollment | Allocation | T1 | T2 |
|---|---|---|---|---|
| Inclusion and exclusion criteria | X | |||
| Age | X | |||
| Assessment | ||||
| Homa IR | X | X | ||
| Weight & BMI | X | X | ||
| WHR | X | X | ||
| FSH/LH Ratio | X | X | ||
| Interventions | ||||
| Iso-caloric low glycemic diet | ||||
| Aerobic exercise | ||||
| WBV | ||||
Patients’ physical characteristics
| Study group Mean ± SD | Control group Mean ± SD | T-value | p-value | |
|---|---|---|---|---|
| Age (years) | 27.86 ± 3.88 | 27.56 ± 4.14 | − 0.92 | 0.36a |
| Height (m) | 1.64 ± 0.04 | 1.65 ± 0.03 | 0.25 | 0.79a |
| Menstrual frequency (oligomenorrhea/normal/amenorrhea) | 19 | 17 | 0.72a | |
| Menstrual regularity (regular/irregular) | 3 regular/ 20 irregular | 5 regular/ 18 irregular | χ2 = 0.61 | 0.43a |
| Numbers of pads per day (average/heavy/mild) | 9 average/ 14 heavy/ 0 mild | 10 average/ 13 heavy/ 0 mild | 0.77a | |
| Dysmenorrhea (mild/moderate/severe) | 5 mild/ 10 moderate/ 9 severe | 6 mild/ 8 moderate/ 9 severe | χ2 = 0.37 | 0.83a |